GSK2334470
SIGMA/SML0217 - ≥98% (HPLC)
Synonym: (3S,6R)
CAS Number: 1227911-45-6
Empirical Formula (Hill Notation): C25H34N8O
Molecular Weight: 462.59
MDL Number: MFCD21608525
Linear Formula: C25H34N8O
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to light brown |
form | powder |
InChI | 1S/C25H34N8O/c1-15-8-9-17 |
InChI key | QLPHOXTXAKOFMU-WBVHZDCISA |
Quality Level | 100 |
SMILES string | CNc1nc(cc(n1)-c2ccc3c(N)n |
solubility | DMSO: ≥10 mg/mL |
storage temp. | 2-8°C |
Application: | GSK2334470 has been used as an inhibitor of 3-phosphoinositide dependent protein kinase-1 (PDK-1) in: • Treg cells, to identify regulators of interleukin 2 (IL-2)– signal transducer and activator of transcription 5 (STAT5) signaling • glycodelin-transfected HEC-1B human endometrial adenocarcinoma cells. • HeLa and Hs578T cells to test its effect on formylglycinamidine ribonucleotide synthase (FGAMS) assembly |
Biochem/physiol Actions: | GSK2334470 (GSK-470) mediates cell cycle arrest. It also inhibits cellular proliferation and induces apoptosis in cancer cells. |
Biochem/physiol Actions: | GSK2334470 is a highly specific and potent inhibitor of PDK1 (3-Phosphoinositide dependent protein kinase-1). GSK2334470 can be used in cells to ablate T-loop phosphorylation and activation SGK, S6K1 and RSK as well as suppress the activation of Akt. |
Other Notes: | GSK2334470 has been expertly reviewed and recommended by the Chemical Probes Portal. For more information, please visit the GSK2334470 probe summary on the Chemical Probes Portal website. |
Packaging: | 5, 25 mg in glass bottle |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |